With box warnings

Without box warnings

Branded

Generic

3 results

bicalutamide
(Bicalutamide)
Golden State Medical Supply, Inc.
Usage: Bicalutamide tablets are indicated for use in combination with a luteinizing hormone-releasing hormone (LHRH) analog to treat Stage D2 metastatic carcinoma of the prostate. The 150 mg dose is not approved for standalone use or with other treatments.
nilandron
(Nilutamide)
Concordia Pharmaceuticals Inc.
Usage: NILANDRON tablets are indicated for use in combination with surgical castration to treat metastatic prostate cancer (Stage D2). Treatment should start on the same day or the day after surgical castration for optimal effectiveness.
nilutamide
(Nilutamide)
Prasco Laboratories
Usage: Nilutamide tablets are indicated for use alongside surgical castration to treat metastatic prostate cancer (Stage D2). For optimal effectiveness, treatment with Nilutamide should start on the same day as or the day after the surgical procedure.

Medications for Metastatic Prostate Carcinoma

bicalutamide